TRCT
PRAX icon

Tower Research Capital (TRC)’s Praxis Precision Medicines PRAX Stock Holding History

Tower Research Capital (TRC)’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$429K Buy
1,333
+722
+118% +$223K 0.01% 1023
2025
Q4 		$180K Sell
611
-1,516
-71% -$282K ﹤0.01% 1511
2025
Q3 		$113K Buy
2,127
+290
+16% +$14.1K ﹤0.01% 1905
2025
Q2 		$77.2K Buy
1,837
+359
+24% +$13.7K ﹤0.01% 2598
2025
Q1 		$56K Sell
1,478
-4,395
-75% -$274K ﹤0.01% 2154
2024
Q4 		$452K Buy
5,873
+4,990
+565% +$361K 0.01% 1142
2024
Q3 		$50.8K Sell
883
-636
-42% -$34.4K ﹤0.01% 2712
2024
Q2 		$62.8K Sell
1,519
-329
-18% -$15.5K ﹤0.01% 2924
2024
Q1 		$113K Buy
+1,848
New +$82.9K ﹤0.01% 1765
2023
Q3 		– Sell
-746
Closed -$12.9K – 6165
2023
Q2 		$12.9K Sell
746
-75
-9% -$1.15K ﹤0.01% 3825
2023
Q1 		$10K Sell
821
-952
-54% -$40.2K ﹤0.01% 4392
2022
Q4 		$63K Buy
1,773
+637
+56% +$19.9K ﹤0.01% 2169
2022
Q3 		$39K Buy
1,136
+211
+23% +$10.5K ﹤0.01% 3383
2022
Q2 		$34K Buy
925
+611
+195% +$65.2K ﹤0.01% 3252
2022
Q1 		$48K Buy
314
+226
+257% +$46.4K ﹤0.01% 2769
2021
Q4 		$26K Buy
88
+12
+16% +$3.52K ﹤0.01% 3394
2021
Q3 		$21K Sell
76
-210
-73% -$57K ﹤0.01% 3673
2021
Q2 		$78K Buy
286
+217
+314% +$77.7K ﹤0.01% 2629
2021
Q1 		$34K Buy
69
+44
+176% +$31.3K ﹤0.01% 3463
2020
Q4 		$20K Buy
+25
New +$14.6K ﹤0.01% 3877

Other funds holding PRAX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Tower Research Capital (TRC)'s PRAX Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Praxis Precision Medicines (PRAX) stake by 118% in Q1 2026, buying an estimated $223K and bringing the position to 1,333 shares worth $429K. The position accounts for 0.01% of the portfolio, ranked #1023.

Tower Research Capital (TRC) first reported a position in PRAX in Q4 2020 and has held it in 20 quarters since. The position peaked at $452K in Q4 2024. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

  • Tower Research Capital (TRC) held 1,333 shares of Praxis Precision Medicines worth $429K as of Q1 2026.
  • Tower Research Capital (TRC) bought 722 Praxis Precision Medicines shares in Q1 2026, an estimated $223K.
  • Praxis Precision Medicines made up 0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #1023 holding.
  • Tower Research Capital (TRC) first reported a position in Praxis Precision Medicines in Q4 2020 and has held it in 20 quarters since.
  • Tower Research Capital (TRC)'s Praxis Precision Medicines position peaked at $452K in Q4 2024.
  • 289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.